712 related articles for article (PubMed ID: 18449905)
1. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
2. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
3. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
6. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
7. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
[TBL] [Abstract][Full Text] [Related]
9. Porcine sinus mucosa holds cells that respond to bone morphogenetic protein (BMP)-6 and BMP-7 with increased osteogenic differentiation in vitro.
Gruber R; Kandler B; Fuerst G; Fischer MB; Watzek G
Clin Oral Implants Res; 2004 Oct; 15(5):575-80. PubMed ID: 15355400
[TBL] [Abstract][Full Text] [Related]
10. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
11. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
Yeh LC; Tsai AD; Zavala MC; Lee JC
J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
13. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice.
Kadowaki A; Tsukazaki T; Hirata K; Shibata Y; Okubo Y; Bessho K; Komori T; Yoshida N; Yamaguchi A
Bone; 2004 Jun; 34(6):993-1003. PubMed ID: 15193545
[TBL] [Abstract][Full Text] [Related]
15. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
Kodama T; Goto T; Miyazaki T; Takahashi T
Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
[TBL] [Abstract][Full Text] [Related]
16. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
17. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
18. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
20. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway.
Richardson JA; Amantea CM; Kianmahd B; Tetradis S; Lieberman JR; Hahn TJ; Parhami F
J Cell Biochem; 2007 Apr; 100(5):1131-45. PubMed ID: 17031848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]